Odyssean »

Repay Hldgs Corp shares owned by Odyssean

Quarter-by-quarter ownership of Repay Hldgs Corp (RPAY) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Repay Hldgs Corp

Tip: Access up to 7 years of quarterly data

All positions including Repay Hldgs Corp held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Repay Hldgs Corp by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $226k 54k 4.20

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Repay Hldgs Corp

Forager Capital Management
Private Management Group
BlackRock
American Century Companies
AQR Capital Management
Vanguard Capital Management
Dimensional Fund Advisors
Whetstone Capital Advisors
Pacific Ridge Capital Partners
State Street Corporation
Geode Capital Management
D. E. Shaw & Co
Morgan Stanley
Vanguard Portfolio Management
Nuveen

View all funds holding Repay Hldgs Corp